Adipocytokine signaling pathway, non-alcoholic fatty liver disease, negative regulation of insulin receptor signaling pathway, type II diabetes mellitus, insulin resistance, negative regulation of inflammatory response, TNF signaling pathway. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.